Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)
China · Delayed Price · Currency is CNY 23.63
+0.22 (0.94%)
Sep 7, 2026, 3:04 PM CST
SHE:301206 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 4,726 | 5,258 | 5,291 | 5,843 | 7,891 | - | |
Market Cap Growth | -19.21% | -0.62% | -9.45% | -25.95% | - | - |
Enterprise Value | 3,419 | 4,620 | 5,074 | 5,725 | 7,376 | - |
Last Close Price | 23.63 | 25.75 | 24.15 | 26.22 | 34.59 | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 56.16 | 57.52 | 50.41 | 104.38 | 48.21 | - |
Forward PE | - | 37.39 | 36.92 | 58.34 | 37.32 | - |
PS Ratio | 6.22 | 8.10 | 7.42 | 11.70 | 11.69 | - |
PB Ratio | 1.13 | 1.24 | 1.18 | 1.29 | 1.71 | - |
P/TBV Ratio | 1.15 | 1.26 | 1.19 | 1.30 | 1.73 | - |
P/OCF Ratio | 49.99 | 230.46 | - | 101.96 | 93.64 | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
EV/Sales Ratio | 4.50 | 7.11 | 7.12 | 11.46 | 10.93 | - |
EV/EBITDA Ratio | 28.63 | 45.14 | 68.60 | 17650.05 | 106.40 | - |
EV/EBIT Ratio | 85.48 | 160.11 | 658.36 | - | 241.21 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Debt / Equity Ratio | -0.31 | -0.14 | -0.63 | -0.02 | -0.11 | -0.49 |
Net Debt / EBITDA Ratio | -10.94 | -5.85 | -38.26 | -335.44 | -7.05 | -0.80 |
Net Debt / FCF Ratio | 23.40 | 3.39 | 18.21 | 1.66 | 3.09 | -2.48 |
Asset Turnover | 0.17 | 0.14 | 0.15 | 0.10 | 0.21 | 1.39 |
Inventory Turnover | 3.27 | 3.45 | 5.14 | 4.83 | 5.62 | 10.80 |
Quick Ratio | 5.95 | 6.11 | 13.26 | 0.88 | 2.67 | 1.20 |
Current Ratio | 7.23 | 18.34 | 13.90 | 1.44 | 3.23 | 1.43 |
Return on Equity (ROE) | 1.98% | 2.09% | 2.33% | 1.22% | 5.78% | 68.85% |
Return on Assets (ROA) | 0.56% | 0.39% | 0.10% | -0.77% | 0.59% | 31.89% |
Return on Invested Capital (ROIC) | 1.16% | 0.94% | 0.21% | -1.32% | 1.17% | 130.74% |
Return on Capital Employed (ROCE) | 0.90% | 0.70% | 0.20% | -1.30% | 0.70% | 57.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Earnings Yield | 1.78% | 1.74% | 1.98% | 0.96% | 2.07% | - |
FCF Yield | -1.18% | -3.35% | -2.94% | -1.12% | -2.01% | - |
Dividend Yield | 4.29% | 3.88% | 5.80% | 0.95% | 2.02% | - |
Payout Ratio | 129.68% | 381.41% | 77.08% | 255.72% | 82.40% | - |
Buyback Yield / Dilution | 0.35% | 1.54% | -0.95% | -0.16% | -31.61% | 0.00% |
Total Shareholder Return | 4.64% | 5.42% | 4.85% | 0.80% | -29.59% | 0.00% |